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Abstract: In the present study we investigate the consequences of TLR4 activation by LPS for the synthesis of
a proliferation-inducing ligand (APRIL) by human neutrophils (PMNs), and the possible role of the ERK1/2
kinases signaling pathway. In order to make a comparison, the same examinations were carried out on autolo-
gous peripheral blood mononuclear cells (PBMCs). The levels of mRNA for APRIL and TLR4 were measured
using the real-time PCR method. Western blot analysis was used to assay the expressions of APRIL and ERK1/2
in cell lysates. We discovered an increased expression of APRIL accompanying the increased expression of
TLR4 in the LPS-stimulated PMNs and PBMCs. Furthermore, stimulation with LPS triggered similar changes
in phospho-ERK1/2 proteins expression in those cells. The present study suggests that LPS plays a role in TLR4-
-ligation in APRIL induction through ERK1/2 pathway activation in human neutrophils and mononuclear cells
of peripheral blood. The association between TLR4 activation and APRIL expression in examined leukocytes
might have important implications for the immune response of the host exposed to TLR4 ligands such as LPS.
(Folia Histochemica et Cytobiologica 2012, Vol. 50, No. 2, 196–202)
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Introduction
Toll-like receptor 4 (TLR4) is a member of the pat-
tern recognition receptors family (PRRs), recogniz-
ing pathogens components, known as pathogen-as-
sociated molecular patterns (PAMPs) [1, 2]. TLR4 is
essential for responses to LPS, a major constituent of
the outer membrane of Gram-negative bacteria [1].
It has also been reported that TLR4 is involved in
the recognition and elimination of respiratory syncy-
tial virus (RSV) and C. albicans [1, 2]. Furthermore,
TLR4 has been shown to recognize endogenous
ligands, including heat shock proteins (HSP60 and
HSP70), oligosaccharides of hyaluronic acid, heparin
sulfate and fibrinogen [2].
TLR4, similarly to TLR1, TLR2, TLR5, TLR6 and
TLR11, is expressed on the immune cell surface, in-
volving neutrophils [1, 3, 4]. Human neutrophils
(PMNs), the primary effector cells of the early phase
of the immune response, express not only TLR4 but
also the majority of identified TLRs, which trigger
the different biological functions of those cells [4].
It is well documented that TLR4 activation in neu-
trophils by LPS up-regulates chemokine receptor ex-
pression and function, promotes adhesion, degranu-
lation and phagocytosis, and enhances the produc-
tion of reactive oxygen species and a wide range of
cytokines by these cells [5–7].
Available data indicates that the recognition of
specific ligands by different TLRs may be responsi-
ble for changes in the ability of different immune cells
to secrete cytokines belonging to TNF superfamily
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proteins such as TNF-related apoptosis-inducing
ligand (TRAIL), B-cell activating factor (BAFF/Blys),
and a proliferation-inducing ligand (APRIL) [8–12].
These TNF superfamily proteins play diverse roles in
the proliferation, growth and survival of normal and
pathological cells [10, 13–15]. For example, TRAIL
exerts a tumor-inhibiting activity associated with se-
lective induction of apoptosis in tumor cells [15]. In
contrast, APRIL and BAFF demonstrate a tumor-
promoting activity through the inhibition of apopto-
sis in neoplastic cells [13].
In human neutrophils, the TLR4 receptor has
been shown to induce the synthesis of TRAIL [11].
Studies by Scapini et al. indicate that TLR4 recep-
tor does not influence the BAFF gene and protein
expression in neutrophils [10]. There is no data avail-
able on the regulation of APRIL expression in neu-
trophils.
In contrast to other molecules belonging to the
TNF superfamily, APRIL, also known as TNFSF13
or TALL-2, only exists as a secreted soluble ligand
[13]. The APRIL molecule is closely related to
BAFF/Blys that binds TACI and BCMA, but not to
BAFF-R, which are BAFF-specific receptors [13].
APRIL has been shown to bind heparin sulfate pro-
teoglycans (HSPG) on cell surfaces as well as in the
extracellular matrix [16]. Kimberley et al. have sug-
gested that proteoglycan binding domain of APRIL
serves as a platform for ligand multimerization and
cross-linking [17].
The biological effect of TLR4 ligation is usually
associated with the activation of four major signal-
ing pathways: nuclear factor (NF-kB) pathway and
mitogen-activated protein kinases (MAPKs) path-
ways; the extracellular signal-regulated kinase
(ERK); c-Jun NH2-terminal kinase (JNK); and p38
mitogen activated protein kinase [2, 18]. A signal-
ing pathway involving ERK activation appears to
play a crucial role in the induction of biological ef-
fects of neutrophils, since it contributes to enhanced
translocation of NF-kB [19]. A number of isoforms
of ERK have been described; two of them, ERK-1
(p44MAPK) and ERK-2 (p42MAPK), are expressed
in neutrophils and play a role in the regulation of their
functions [20].
Taking the above into consideration, in the present
study we have investigated the consequences of TLR4
ligation by LPS on the APRIL induction in human
neutrophils and, for comparison, in autologous mono-
nuclear cells of peripheral blood (PBMCs). Obtained
results suggest that TLR4 activation may lead to an
elevated expression of APRIL molecule in human
neutrophils and mononuclear cells through ERK-1/2
kinases signaling pathway.
Material and methods
Isolation of PMNs and PBMCs. The cells were isolated from
human whole blood treated with EDTA by way of density
centrifugation, using Polymorphprep (Axis-Shield, Oslo,
Norway) (density — 1.113 g/ml). This method enables si-
multaneous separation of two highly purified leukocyte frac-
tions: polymorphonuclear cells, involving neutrophils
(PMNs) and mononuclear cells (PBMCs). The purity of iso-
lated PMNs and PBMCs was determined by May-
-Grunewald-Giemsa-staining.
After washing in PBS without CaCl2 and MgCl2 (Gibco,
Paisley, UK) the PMNs were separated by magnetic selection.
CD16 positive neutrophils separation. Neutrophils were
separated by positive selection using a Midi MACS mag-
netic separation system (Miltenyi Biotec, Germany). Iso-
lated cells were suspended in MACS Buffer (up to 5 × 107
total cells) and incubated with CD16 MicroBeads for 30
min at 4–8°C. After washing, the cells were suspended in
MACS Buffer.
Culture of neutrophils and mononuclear cells. The sepa-
rated neutrophils and mononuclear cells were suspended in
the culture medium (RPMI-1640) to provide 5 × 106 cells/ml
and incubated in flat-bottomed 96-well plates (Microtest
III-Falcon, Franklin Lakes, NJ, USA) for 20 h at 37°C in
a humidified incubator with 5% CO2 (NUAIRE
™). LPS
(10 ng/ml; Sigma) was tested to stimulate the expression of
TLR4 and APRIL in both kinds of leukocytes. The viability of
neutrophils measured after incubation was 72%, mononucle-
ar cells — 76%, as determined by trypan blue exclusion.
To investigate the role of ERK1/2 kinase in the APRIL
synthesis mediated through TLR4 ligation, we assessed the
activation thereof by determining the phosphorylation sta-
tus of this kinase in LPS-stimulated cells by using p42/p44
MAPK inhibitor PD98059 (2’-amino-3’-methoxyflavone),
a peptid that specifically inhibits ERK1/2 activation. After
isolation, the cells were treated with PD98059 (Calbiochem,
Bad Soden, Germany) (40 µM) for one hour before LPS
stimulation. The presence of inhibitor did not affect cell
viability.
RNA isolation and cDNA synthesis. For real-time PCR, total
RNA was isolated from 107 untreated and stimulated neu-
trophils or peripheral blood mononuclear cells (RNeasy
Mini Kit, Qiagen, Hilden, Germany), according to the man-
ufacturer’s specification. The quantity of RNA was verified
by spectrophotometry (QuantGen Biopharmacia). RNA
integrity was verified by 1.5% agarose gel electrophoresis
identified by ethidium bromide staining and OD260/280 ab-
sorbance ratio > 1.95. One microgram of total RNA was
used to prepare cDNA. cDNA synthesis was performed
using SuperScript™ First-Strand Synthesis System for
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RT-PCR (Invitrogen), according to the manufacturer’s spec-
ification in the MJ Research Thermal Cycler (Model
PTC-200, Watertown, MA, USA).
Real-time PCR. Transcript levels were measured by real-
time PCR using human genes QuantiTec Hs_TLR4_2_SG
Assay (Qiagen), QuantiTec Hs_TNFSF13_2_SG Assay
(Qiagen) and QuantiTec Hs_PRS18_1_SG Assay (s18)
(Qiagen) as normalizer.
Real-time PCR was performed in duplicate in 20 µl us-
ing the QuantiTect SYBR Green PCR Master Mix (Qiagen)
following the manufacturer’s instructions, and carried out
in the Chromo4 Real-time PCR Detector (Bio-Rad Labo-
ratories, Hercules, CA, USA). The thermal cycling condi-
tions included an initial activation step at 95°C for 15 min-
utes, followed by 40 cycles of denaturation, annealing and
amplification (95°C for 30 s, 55°C for 30 s, 72°C for 30 s). At
the end of the amplification phase, a melting curve analysis
was carried out on the product. Fluorescent data collection
was performed during the annealing step.
A standard curve structure was generated employing
a series of four dilutions of cDNA, derived from unstimu-
lated cells in reaction with the house-keeping gene — s18.
Based on those curves, the levels of total TLR4 and
TNFSF13 transcripts were calculated after normalization of
TLR4 and TNFSF13 products to s18. The value of CT was
determined by the first cycle number at which florescence
was greater that the set threshold value. To calculate our
data, we used the comparative CT method for relative quan-
tification (DCT method).
Western blot. Cytoplasmic protein fractions of neutrophils and
mononuclear cells were analyzed with the use of Western blot
for APRIL protein expression and the activation of ERK1/2
kinases by determining their phosphorylation status.
Cells were lysed directly in the presence of Protease In-
hibitor Cocktail (Sigma-Aldrich, Steinheim, Germany) by
sonication, using Vibra-Cell Ultrasonic Processor (Sonics
& Materials, Inc., USA). Protein fractions were suspended
in Laemmli buffer (Bio-Rad Laboratories, Hercules, CA,
USA) and next electrophorezed on SDS-PAGE. The re-
solved protein was transferred onto 0.2 µm pore-sized ni-
trocellulose (Bio-Rad Laboratories, Hercules, CA, USA).
The nitrocellulose was incubated at 4°C for 4 h with the
respective primary polyclonal antibody: anti-APRIL (R&D
Systems), anti-phospho ERK1/2 (1:100; Santa Cruz Biotech-
nology, Heidelberg, Germany).
After washing in 0.1% TBS-T, the membrane was incu-
bated at room temperature for one hour with alkaline phos-
phatase anti-mouse IgG Abs (Vector Laboratories, Burlin-
game, CA, USA). Immunoreactive protein bands were visu-
alized following the addition of BCIP/NBT Liquid Substrate
System (Sigma-Aldrich, Steinheim, Germany), determined
using IMAGEJ (public domain, Java-based image process-
ing program developed at the National Institutes of Health,
USA) software and estimated by arbitrary units (AU).
The antibody against beta-actin (1:1000; Santa Cruz Bio-
technology), which detects the expression of beta-actin in
cells lysates, was used as an internal control.
Statistical analysis. Statistical analysis was performed with
a statistical package — Statistica 6.0 software. Nonparamet-
ric U Mann–Whitney test was used. Results were expressed
as median, minimum, and maximum values. For analysis
correlation, Pearson’s linear correlation was used. P values
below 0.05 were considered to be statistically significant.
Results
mRNA expression of APRIL and TLR4
analyzed by real-time PCR
Real-time-PCR analysis revealed increased relative
expression of APRIL-mRNA levels in neutrophils
stimulated with LPS, compared to unstimulated cells.
Similarly to APRIL, mRNA levels of TLR4 also in-
creased in these cells (Figure 1).
Treatment of mononuclear cells with LPS also led
to elevated APRIL-mRNA and TLR4-mRNA ex-
pressions. It is important to note that the expressions
of APRIL-mRNA as well as TLR4-mRNA in PBMCs
were significantly lower than in PMNs (Figure 1).
Analysis of relationships between APRIL and
TLR4 expressions showed correlations in neutrophils
and mononuclear cells treated with LPS (r = 0.79,
p < 0.05 and 0.91, p < 0.05 respectively).
Expressions of APRIL and phospho-ERK1/2
assessed by the Western blot method
Western blot analysis showed that the lysates of
neutrophils and mononuclear cells contained a 27 kDa
protein that was stained by anti-APRIL polyclonal
antibody (Figure 2A). The obtained results demon-
strated significantly enhanced expression of APRIL
in examined cells stimulated with LPS compared to
unstimulated cells. However, the expression of
APRIL in unstimulated and LPS-stimulated neutro-
phils was lower than in autologous mononuclear cells.
To measure the mechanism of LPS-induced
APRIL expression, levels of ERK1/2 kinases (42 and
44 kDa) were detected. Exposure of neutrophils and
mononuclear cells to LPS increased the levels of phos-
phorylated ERK1/2 (Figure 2B). Similarly to APRIL
detected by Western blot analysis, the expression of
ERK1/2 in neutrophils was lower than in autologous
mononuclear cells.
To confirm the participation of ERK1/2 pathway
in the induction of APRIL expression in examined
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Figure 1. Effects of lipopolysaccharide (LPS) on the expression of APRIL-mRNA and TLR4-mRNA. RT-PCR was
performed on human neutrophils and mononuclear cells from peripheral blood. mRNA of TLR4 and APRIL levels were
normalized to house-keeping gene — s18. *statistically significant differences between unstimulated and stimulated cells
(p < 0.05); astatistically significant differences between neutrophils and mononuclear cells (p < 0.05). Each value repre-
sents the median ± minimum and maximum for n = 10
leukocytes treated with LPS, the levels of phosphory-
lated ERK1/2 and APRIL expressions in the pres-
ence of a selective inhibitor of this pathway (PD98059)
were assessed. Increased APRIL and ERK1/2 pro-
teins expression induced by LPS were abrogated in
the presence of PD98059 (Figures 2A, B). This ob-
servation confirms that ERK1/2 play the role of a crit-
ical messenger in TLR4-mediated induction of
APRIL.
Discussion
Available data concerning the regulation of APRIL
expression in the immune cells showed that this mol-
ecule was detected in monocytes/macrophages and
dendritic cells treated with IFNs, CD40L or TLR ag-
onists CpG and poly(IC) [12, 14].
The current study has provided the first evidence
that activation of TLR4 receptor is essential for the
synthesis of APRIL in human neutrophils. In-
creased relative expression of APRIL-mRNA ac-
companied the increased relative expression of
TLR4-mRNA in response to LPS treatment. Simi-
lar changes were found in autologous mononucle-
ar cells, but expressions of mRNA for APRIL, as
well as for TLR4 in those cells, were significantly
lower than those in neutrophils. The presence of
correlations between mRNA for APRIL and TLR4
in both types of leukocytes appears to confirm the
influence of TLR4 ligation by LPS on the expres-
sion of APRIL molecule.
Higher expression of TLR4 in neutrophils than
in mononuclear cells suggests major sensitivity of
neutrophils on a specific ligand — LPS — which can
lead to more enhanced effects mediated by this re-
ceptor. Similar to TLR4-mRNA, the differences in
APRIL expression between examined leukocytes
demonstrated in the study appear to confirm this
assertion.
Data including changes in APRIL expression at
the mRNA levels, analyzed by real time-PCR, differed
from the results obtained at the protein level by West-
ern blot analysis. Conversely to mRNA levels, the
expression of APRIL protein in PMNs was lower than
in PBMCs. A possible explanation of these differences
may be the more effective mechanism responsible for
processing APRIL in PBMCs than that in PMNs. It
is known that APRIL is processed by furin pro-pro-
tein convertase inside the Golgi apparatus in mye-
loid cells, prior to the creation of the form that is then
secreted as bioctive soluble molecule [14]. It is prob-
able that the activity of this convertase in PMNs is
lower than in PBMCs. Further examinations may be
helpful in clarifying this issue. However, taking into
consideration the quantitative dominance of neutro-
phils in the peripheral blood, the expression of APRIL
at mRNA and protein levels in those cells may have
important implications for the immune response of
host exposed to LPS as well as to other exogenous or
endogenous ligands for TLR4 receptor [1, 2].
Increased expression of APRIL can influence the
lifespan and proliferation of B-cells through trans-
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mitting a survival signal into plasmablast/plasma cells.
Furthermore, this molecule is involved in the induc-
tion of activation-induced deaminase (AID), which
is indispensable for Ig-class switching recombinations
[13, 21–23]. These functions suggest that enhanced
expression and secretion of APRIL may be involved
in autoimmune diseases with a humoral component,
such as rheumatic diseases [24]. It has been suggested
that neutrophils presenting in the synovium through
the APRIL production might play an essential role in
the development of rheumatoid arthritis [25].
Elevated synthesis of APRIL by neutrophils and
mononuclear cells in response to stimulation by LPS,
as presented in the current study, may also impact
the cellular immune response. It has been demon-
strated that APRIL may up-regulate cofactors such
as CD40, MHC II and B7.1 and B7.2 on B-cells, which
facilitate antigen presentation to T-cells and lead to
their activation, proliferation and survival [16, 21].
High expression of APRIL triggered by TLR4 li-
gation can also affect cancer development. Available
data indicates tumor-promoting activity of APRIL,
not only in various B-cell malignancies but also in
human cancer of colon, thyroid or breast [26–29].
Moreaux et al. demonstrated that APRIL activated
NF-kB, PI-3kinase/AKT, and MAPK kinase pathways
in myeloma cells and induced a strong up-regulation
of the antiapoptotic proteins Mcl-1 and Bcl-2 [28].
Gupta et al. reported that APRIL mediates follicular
lymphoma B-cell proliferation [29]. Furthermore,
APRIL, through binding heparin sulfate proteogly-
cans (HSPG) on the surface of tumor cells, may ini-
Figure 2A. Western blot analysis of APRIL and phospho-ERK1/2 (B) protein expression in neutrophils and mononuclear
cells incubated for 20 h without or in the presence of LPS and inhibitor PD98059 (40 µM). Bands intensity in blot
was quantified using Image J method. *statistically significant differences between unstimulated and stimulated cells
(p < 0.05); astatistically significant differences between cells stimulated by LPS and cells incubated with PD98059
before stimulation with LPS (p < 0.05); bstatistically significant differences between neutrophils and mononuclear
cells (p < 0.05)
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tiate a solid tumor growth through the regulation of
tumor cells adhesion and invasion [16, 17].
To explain the mechanism of LPS-induced APRIL
expression, we proved that LPS activates the expression
of APRIL in human neutrophils and mononuclear cells
via ERK1/2 kinases signaling pathway. Similarly to
APRIL, the expressions of phospho-ERK1/2 proteins
in PMNs were significantly lower than in PBMCs.
The above differences appear to confirm the more
effective role of PBMCs than PMNs in forming a bi-
ologically active APRIL molecule. Additionally, up-
regulation of ERK1/2 phosphorylation in the cells
treated with LPS may cause enhancement of NF-kB
translocation and transactivation, leading to more
transcriptional activation of cytokine genes, involv-
ing APRIL in examined leukocytes [30, 31].
Conclusions
Our preliminary study suggests a potential role of
TLR4 ligation by LPS in the ERK1/2-mediated ex-
pression of APRIL in human neutrophils, as well as
mononuclear cells of peripheral blood. Those obser-
vations seem to indicate a new aspect of functions of
these leukocytes associated with TLR4 activation.
Further research, involving patients with autoimmune
or cancer diseases, may confirm the potential signifi-
cance of the presented findings.
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